Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

UCSF and Gladstone scientists identified two FDA-approved cancer drugs that reversed Alzheimer’s symptoms in mice, showing promise for repurposed treatment through gene expression reversal and ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that ...

With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling ...

Scientists use a precise form of gene editing called prime editing to correct the most common genetic mutations that cause alternating hemiplegia of childhood, a rare and severe neurological disorder ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

A study comparing the gene expression signature of Alzheimer's disease with those elicited by 1,300 approved drugs found a combination of two cancer medications that could treat the most common form ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe ...

Scientists have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s ...

By the time they are a few months old, infants born with alternating hemiplegia of childhood (AHC) begin experiencing ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that ...